Pieris napi chromosome 11, ilPieNapi1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Pieridae; Pierinae; Pieris.
REFSEQ INFORMATION: The reference sequence is identical to\nFR997705.1.\nAssembly name: ilPieNapi1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/01/30. The original whole-genome shotgun project has the\naccession CAJQFT000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Pieris napi Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 91% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized protein KIAA0754-like, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized protein KIAA0754-like, transcript variant X2
uncharacterized protein KIAA0754-like, transcript variant X1
uncharacterized protein KIAA0754-like isoform X3
uncharacterized protein KIAA0754-like isoform X2
uncharacterized protein KIAA0754-like isoform X1
membrane-bound alkaline phosphatase-like
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9, transcript variant X2
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
acetyl-CoA acetyltransferase A, mitochondrial-like
microprocessor complex subunit DGCR8, transcript variant X6
microprocessor complex subunit DGCR8, transcript variant X2
microprocessor complex subunit DGCR8, transcript variant X3
microprocessor complex subunit DGCR8, transcript variant X1
microprocessor complex subunit DGCR8, transcript variant X4
microprocessor complex subunit DGCR8, transcript variant X5
microprocessor complex subunit DGCR8, transcript variant X7
microprocessor complex subunit DGCR8 isoform X1
microprocessor complex subunit DGCR8 isoform X2
microprocessor complex subunit DGCR8 isoform X3
uncharacterized LOC125053968, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125053968, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125053968, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125053968, transcript variant X5
uncharacterized LOC125053968, transcript variant X4
uncharacterized LOC125053968, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized protein LOC125053968 isoform X2
uncharacterized protein LOC125053968 isoform X3
uncharacterized protein LOC125053968 isoform X1
uncharacterized protein LOC125053968 isoform X5
uncharacterized protein LOC125053968 isoform X4
uncharacterized protein LOC125053968 isoform X6
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1-A, transcript variant X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1-A isoform X1
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1-A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 167 samples with support for all annotated introns
SWI/SNF-related matrix-associated actin-dependent regulator of chromatin subfamily B member 1-A isoform X2
putative tricarboxylate transport protein, mitochondrial
uncharacterized LOC125053862, transcript variant X2
uncharacterized LOC125053862, transcript variant X1
uncharacterized LOC125053863, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC125053863, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
CCR4-NOT transcription complex subunit 10
myotubularin-related protein 4, transcript variant X7
myotubularin-related protein 4, transcript variant X2
myotubularin-related protein 4, transcript variant X4
myotubularin-related protein 4, transcript variant X6
myotubularin-related protein 4, transcript variant X1
myotubularin-related protein 4, transcript variant X3
myotubularin-related protein 4, transcript variant X5
myotubularin-related protein 4 isoform X2
myotubularin-related protein 4 isoform X4
myotubularin-related protein 4 isoform X1
myotubularin-related protein 4 isoform X3
myotubularin-related protein 4 isoform X5
putative mediator of RNA polymerase II transcription subunit 24
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 68% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
uncharacterized LOC125053528, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC125053528, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
uncharacterized protein LOC125053528 isoform X2
uncharacterized protein LOC125053528 isoform X1
phosphorylase b kinase gamma catalytic chain, liver/testis isoform, transcript variant X1
phosphorylase b kinase gamma catalytic chain, liver/testis isoform, transcript variant X3
phosphorylase b kinase gamma catalytic chain, liver/testis isoform, transcript variant X2
phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform isoform X1
phosphorylase b kinase gamma catalytic chain, liver/testis isoform isoform X2
max-binding protein MNT-like, transcript variant X4
max-binding protein MNT-like, transcript variant X2
max-binding protein MNT-like, transcript variant X1
max-binding protein MNT-like, transcript variant X5
max-binding protein MNT-like, transcript variant X6
max-binding protein MNT-like, transcript variant X3
hatching enzyme 1.2-like, transcript variant X1
hatching enzyme 1.2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 121 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 32, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 32, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 32, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 32, transcript variant X4
ubiquitin carboxyl-terminal hydrolase 32 isoform X1
ubiquitin carboxyl-terminal hydrolase 32 isoform X2
ubiquitin carboxyl-terminal hydrolase 32 isoform X3
ubiquitin carboxyl-terminal hydrolase 32 isoform X4
TWiK family of potassium channels protein 18-like
uncharacterized LOC125054171, transcript variant X2
uncharacterized LOC125054171, transcript variant X1
uncharacterized LOC125053869, transcript variant X1
uncharacterized LOC125053869, transcript variant X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon UCG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
potassium channel subfamily K member 15, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
potassium channel subfamily K member 15, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00535
17-beta-hydroxysteroid dehydrogenase 14-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125053993, transcript variant X1
uncharacterized LOC125053993, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 165 samples with support for all annotated introns
homeobox protein cut, transcript variant X5
homeobox protein cut, transcript variant X2
homeobox protein cut, transcript variant X3
homeobox protein cut, transcript variant X1
homeobox protein cut, transcript variant X7
homeobox protein cut, transcript variant X6
homeobox protein cut, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 93 samples with support for all annotated introns
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
myb/SANT-like DNA-binding domain-containing protein 3, transcript variant X1
myb/SANT-like DNA-binding domain-containing protein 3, transcript variant X2
myb/SANT-like DNA-binding domain-containing protein 3
uncharacterized LOC125054002, transcript variant X1
uncharacterized LOC125054002, transcript variant X2
3-oxoacyl-[acyl-carrier-protein] reductase FabG-like
uncharacterized oxidoreductase SSP0419-like
uncharacterized oxidoreductase SERP2049-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
nuclear pore complex protein Nup88, transcript variant X1
nuclear pore complex protein Nup88, transcript variant X2
nuclear pore complex protein Nup88 isoform X1
nuclear pore complex protein Nup88 isoform X2
uncharacterized LOC125053659, transcript variant X1
uncharacterized LOC125053659, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized protein LOC125053659 isoform X1
uncharacterized protein LOC125053659 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 140 samples with support for all annotated introns
uncharacterized LOC125053920, transcript variant X1
uncharacterized LOC125053920, transcript variant X2
vacuolar protein sorting-associated protein 29
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: vacuolar protein sorting-associated protein 29
outer dynein arm-docking complex subunit 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
serine/threonine-protein phosphatase alpha-2 isoform
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 42 homolog
peptidyl-tRNA hydrolase 2, mitochondrial-like
cellular tumor antigen p53-like, transcript variant X1
cellular tumor antigen p53-like, transcript variant X2
cellular tumor antigen p53-like, transcript variant X3
cellular tumor antigen p53-like isoform X1
cellular tumor antigen p53-like isoform X2
HIRA-interacting protein 3-like, transcript variant X1
HIRA-interacting protein 3-like, transcript variant X2
HIRA-interacting protein 3-like, transcript variant X3
HIRA-interacting protein 3-like isoform X1
HIRA-interacting protein 3-like isoform X2
HIRA-interacting protein 3-like isoform X3
proline dehydrogenase 1, mitochondrial, transcript variant X1
proline dehydrogenase 1, mitochondrial, transcript variant X2
proline dehydrogenase 1, mitochondrial isoform X1
proline dehydrogenase 1, mitochondrial isoform X2
uncharacterized LOC125053552, transcript variant X1
uncharacterized LOC125053552, transcript variant X2
uncharacterized LOC125054043, transcript variant X1
uncharacterized LOC125054043, transcript variant X2
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: cytochrome P450 3A19-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 61 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
probable 4-methylmuconolactone transporter
mitochondrial import inner membrane translocase subunit Tim22
uncharacterized LOC125054031, transcript variant X2
uncharacterized LOC125054031, transcript variant X1
uncharacterized protein LOC125054031 isoform X2
uncharacterized protein LOC125054031 isoform X1
nucleoside diphosphate phosphatase ENTPD5, transcript variant X1
nucleoside diphosphate phosphatase ENTPD5 isoform X1
nucleoside diphosphate phosphatase ENTPD5, transcript variant X3
nucleoside diphosphate phosphatase ENTPD5 isoform X3
nucleoside diphosphate phosphatase ENTPD5, transcript variant X2
nucleoside diphosphate phosphatase ENTPD5 isoform X2
nucleoside diphosphate phosphatase ENTPD5, transcript variant X4
nucleoside diphosphate phosphatase ENTPD5 isoform X4
uncharacterized protein CG3556, transcript variant X1
uncharacterized protein CG3556, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC125053693, transcript variant X1
uncharacterized LOC125053693, transcript variant X2
39S ribosomal protein L38, mitochondrial-like
phosphatidylethanolamine-binding protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
phosphatidylethanolamine-binding protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
phosphatidylethanolamine-binding protein 1-like isoform X2
phosphatidylethanolamine-binding protein 1-like isoform X1
phosphatidylethanolamine-binding protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
phosphatidylethanolamine-binding protein 1-like isoform X3
phosphatidylethanolamine-binding protein 1-like
uncharacterized LOC125054108, transcript variant X2
uncharacterized LOC125054108, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 167 samples with support for all annotated introns
zinc finger protein 436-like, transcript variant X3
zinc finger protein 436-like, transcript variant X2
zinc finger protein 436-like, transcript variant X1
zinc finger protein 436-like, transcript variant X4
zinc finger protein 436-like, transcript variant X5
mediator of RNA polymerase II transcription subunit 21
uncharacterized LOC125053946, transcript variant X2
uncharacterized LOC125053946, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
T-box transcription factor TBX1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 55 samples with support for all annotated introns
T-box transcription factor TBX1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
T-box transcription factor TBX1-like isoform X1
T-box transcription factor TBX1-like isoform X2
cell cycle checkpoint protein RAD1, transcript variant X2
cell cycle checkpoint protein RAD1, transcript variant X1
cell cycle checkpoint protein RAD1 isoform X1
cell cycle checkpoint protein RAD1 isoform X2
Golgi SNAP receptor complex member 1, transcript variant X1
Golgi SNAP receptor complex member 1, transcript variant X2
zinc finger imprinted 3-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 51 samples with support for all annotated introns
zinc finger imprinted 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
zinc finger imprinted 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 75 samples with support for all annotated introns
zinc finger imprinted 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 140 samples with support for all annotated introns
armadillo repeat-containing protein 2, transcript variant X3
armadillo repeat-containing protein 2, transcript variant X2
armadillo repeat-containing protein 2, transcript variant X1
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
farnesol dehydrogenase-like, transcript variant X1
farnesol dehydrogenase-like, transcript variant X2
zinc finger protein 239-like, transcript variant X3
zinc finger protein 239-like, transcript variant X2
zinc finger protein 239-like, transcript variant X1
5'-AMP-activated protein kinase catalytic subunit alpha-2
polymerase delta-interacting protein 2, transcript variant X1
polymerase delta-interacting protein 2, transcript variant X2
polymerase delta-interacting protein 2 isoform X2
polymerase delta-interacting protein 2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
short-chain specific acyl-CoA dehydrogenase, mitochondrial
actin-related protein 2/3 complex subunit 3
coiled-coil domain-containing protein 86, transcript variant X2
coiled-coil domain-containing protein 86, transcript variant X1
coiled-coil domain-containing protein 86
signal peptide peptidase-like 3, transcript variant X2
signal peptide peptidase-like 3, transcript variant X1
signal peptide peptidase-like 3 isoform X2
signal peptide peptidase-like 3 isoform X1
nucleolar protein dao-5-like, transcript variant X6
nucleolar protein dao-5-like, transcript variant X5
nucleolar protein dao-5-like, transcript variant X4
nucleolar protein dao-5-like, transcript variant X3
nucleolar protein dao-5-like, transcript variant X2
nucleolar protein dao-5-like, transcript variant X1
uncharacterized protein LOC125053617 isoform X1
CDP-diacylglycerol--inositol 3-phosphatidyltransferase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
MOG interacting and ectopic P-granules protein 1
uncharacterized LOC125053583, transcript variant X2
uncharacterized LOC125053583, transcript variant X1
phenoloxidase subunit 2-like, transcript variant X2
phenoloxidase subunit 2-like, transcript variant X1
2-(3-amino-3-carboxypropyl)histidine synthase subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
elongation of very long chain fatty acids protein AAEL008004-like, transcript variant X1
elongation of very long chain fatty acids protein AAEL008004-like, transcript variant X3
elongation of very long chain fatty acids protein AAEL008004-like, transcript variant X2
elongation of very long chain fatty acids protein AAEL008004-like
splicing factor ESS-2 homolog, transcript variant X1
splicing factor ESS-2 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
uncharacterized LOC125053980, transcript variant X1
uncharacterized LOC125053980, transcript variant X2
uncharacterized protein LOC125053980 isoform X1
uncharacterized protein LOC125053980 isoform X2
cell cycle checkpoint control protein RAD9A
ubiquitin-conjugating enzyme E2 G1, transcript variant X2
ubiquitin-conjugating enzyme E2 G1, transcript variant X3
ubiquitin-conjugating enzyme E2 G1, transcript variant X1
ubiquitin-conjugating enzyme E2 G1 isoform X2
ubiquitin-conjugating enzyme E2 G1 isoform X1
eukaryotic translation initiation factor 4H, transcript variant X1
eukaryotic translation initiation factor 4H, transcript variant X2
eukaryotic translation initiation factor 4H, transcript variant X3
eukaryotic translation initiation factor 4H isoform X1
eukaryotic translation initiation factor 4H isoform X2
eukaryotic translation initiation factor 4H isoform X3
serine/threonine-protein phosphatase 4 catalytic subunit
glucose dehydrogenase [FAD, quinone]-like
glucose dehydrogenase [FAD, quinone]-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 104 samples with support for all annotated introns
uncharacterized LOC125053525, transcript variant X2
uncharacterized LOC125053525, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
myosin tail region-interacting protein MTI1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 104 samples with support for all annotated introns
uncharacterized LOC125053523, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 72 samples with support for all annotated introns
uncharacterized LOC125053523, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
glucose dehydrogenase [FAD, quinone]-like isoform X1
glucose dehydrogenase [FAD, quinone]-like isoform X2
vanin-like protein 2, transcript variant X2
vanin-like protein 2, transcript variant X1
vanin-like protein 1, transcript variant X1
vanin-like protein 1, transcript variant X2
vanin-like protein 1, transcript variant X3
cytosolic 10-formyltetrahydrofolate dehydrogenase
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 7-like
bromodomain-containing protein 1, transcript variant X5
bromodomain-containing protein 1, transcript variant X3
bromodomain-containing protein 1, transcript variant X2
bromodomain-containing protein 1, transcript variant X4
bromodomain-containing protein 1, transcript variant X1
bromodomain-containing protein 1 isoform X3
bromodomain-containing protein 1 isoform X5
bromodomain-containing protein 1 isoform X2
bromodomain-containing protein 1 isoform X4
bromodomain-containing protein 1 isoform X1
calcium release-activated calcium channel protein 1-like, transcript variant X4
calcium release-activated calcium channel protein 1-like, transcript variant X2
calcium release-activated calcium channel protein 1-like, transcript variant X1
calcium release-activated calcium channel protein 1-like, transcript variant X3
calcium release-activated calcium channel protein 1-like isoform X4
uncharacterized protein LOC125053595 isoform X2
uncharacterized protein LOC125053595 isoform X1
uncharacterized protein LOC125053595 isoform X3
26S proteasome non-ATPase regulatory subunit 10-like
methyl-CpG-binding domain protein 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 161 samples with support for all annotated introns
methyl-CpG-binding domain protein 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
methyl-CpG-binding domain protein 4-like isoform X1
methyl-CpG-binding domain protein 4-like isoform X2
jmjC domain-containing histone demethylation protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
transfer RNA phenylalanine (anticodon GAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
LIM/homeobox protein Lhx1, transcript variant X4
LIM/homeobox protein Lhx1, transcript variant X2
LIM/homeobox protein Lhx1, transcript variant X3
LIM/homeobox protein Lhx1, transcript variant X1
trichoplein keratin filament-binding protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 73 samples with support for all annotated introns
trichoplein keratin filament-binding protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 92 samples with support for all annotated introns
trichoplein keratin filament-binding protein
39S ribosomal protein L44, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 133 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
squamous cell carcinoma antigen recognized by T-cells 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 99 samples with support for all annotated introns
neurogenic locus notch homolog protein 1
vacuolar protein sorting-associated protein 33A, transcript variant X2
vacuolar protein sorting-associated protein 33A, transcript variant X1
vacuolar protein sorting-associated protein 33A isoform X2
vacuolar protein sorting-associated protein 33A isoform X1
small G protein signaling modulator 2-like, transcript variant X1
small G protein signaling modulator 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
small G protein signaling modulator 2-like isoform X1
small G protein signaling modulator 2-like isoform X2
serine/threonine-protein kinase Tao, transcript variant X2
serine/threonine-protein kinase Tao, transcript variant X1
serine/threonine-protein kinase Tao, transcript variant X3
serine/threonine-protein kinase Tao isoform X2
serine/threonine-protein kinase Tao isoform X1
serine/threonine-protein kinase Tao isoform X3
chromobox protein homolog 1-like, transcript variant X1
chromobox protein homolog 1-like, transcript variant X2
uncharacterized LOC125053554, transcript variant X1
uncharacterized LOC125053554, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
condensin complex subunit 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
condensin complex subunit 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
peptidoglycan-recognition protein LB-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 139 samples with support for all annotated introns
uncharacterized LOC125053501, transcript variant X1
uncharacterized LOC125053501, transcript variant X2
cytochrome b-c1 complex subunit 6, mitochondrial-like, transcript variant X2
cytochrome b-c1 complex subunit 6, mitochondrial-like, transcript variant X1
cytochrome b-c1 complex subunit 6, mitochondrial-like
histone-lysine N-methyltransferase SETD1, transcript variant X1
histone-lysine N-methyltransferase SETD1, transcript variant X3
histone-lysine N-methyltransferase SETD1, transcript variant X5
histone-lysine N-methyltransferase SETD1, transcript variant X4
histone-lysine N-methyltransferase SETD1, transcript variant X2
histone-lysine N-methyltransferase SETD1 isoform X1
histone-lysine N-methyltransferase SETD1 isoform X2
histone-lysine N-methyltransferase SETD1 isoform X4
histone-lysine N-methyltransferase SETD1 isoform X3
citron rho-interacting kinase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
citron rho-interacting kinase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
citron rho-interacting kinase-like isoform X2
citron rho-interacting kinase-like isoform X1
transmembrane emp24 domain-containing protein 2
ubiquitin carboxyl-terminal hydrolase isozyme L5
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X3
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X2
DNA replication ATP-dependent helicase/nuclease DNA2, transcript variant X1
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X3
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X2
DNA replication ATP-dependent helicase/nuclease DNA2 isoform X1
probable 18S rRNA (guanine-N(7))-methyltransferase
ATP synthase subunit C lysine N-methyltransferase
histone-lysine N-methyltransferase PR-Set7
histone deacetylase 8-like, transcript variant X4
histone deacetylase 8-like, transcript variant X2
histone deacetylase 8-like, transcript variant X1
histone deacetylase 8-like, transcript variant X3
eukaryotic translation initiation factor 3 subunit C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
mediator of RNA polymerase II transcription subunit 31
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
tetratricopeptide repeat protein 28-like
tetratricopeptide repeat protein 28, transcript variant X2
tetratricopeptide repeat protein 28, transcript variant X1
tetratricopeptide repeat protein 28 isoform X2
tetratricopeptide repeat protein 28 isoform X1
unconventional myosin-XVIIIa, transcript variant X1
unconventional myosin-XVIIIa, transcript variant X2
fructose-bisphosphate aldolase-like, transcript variant X2
fructose-bisphosphate aldolase-like, transcript variant X1
fructose-bisphosphate aldolase-like isoform X2
fructose-bisphosphate aldolase-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 202 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
ras-like protein family member 10B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
ras-like protein family member 10B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ras-like protein family member 10B isoform X1
ras-like protein family member 10B isoform X2
aldo-keto reductase AKR2E4-like, transcript variant X3
aldo-keto reductase AKR2E4-like, transcript variant X2
aldo-keto reductase AKR2E4-like isoform X3
aldo-keto reductase AKR2E4-like isoform X2
aldo-keto reductase AKR2E4-like, transcript variant X1
aldo-keto reductase AKR2E4-like isoform X1
facilitated trehalose transporter Tret1-like, transcript variant X1
facilitated trehalose transporter Tret1-like, transcript variant X2
facilitated trehalose transporter Tret1-like isoform X1
facilitated trehalose transporter Tret1-like, transcript variant X3
facilitated trehalose transporter Tret1-like isoform X2
uncharacterized LOC125053544, transcript variant X6
uncharacterized LOC125053544, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC125053544, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC125053544, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC125053544, transcript variant X3
uncharacterized LOC125053544, transcript variant X5
uncharacterized protein LOC125053544 isoform X1
uncharacterized protein LOC125053544 isoform X2
facilitated trehalose transporter Tret1-like
antichymotrypsin-2-like, transcript variant X2
serine protease inhibitor 3/4-like isoform X2
antichymotrypsin-2-like, transcript variant X1
ralA-binding protein 1, transcript variant X2
ralA-binding protein 1, transcript variant X1
ralA-binding protein 1, transcript variant X3
putative glutathione-specific gamma-glutamylcyclotransferase 2
histone acetyltransferase type B catalytic subunit
COORDINATES: nucleotide motif:Rfam:12.0:RF00619
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
outer dynein arm-docking complex subunit 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
larval cuticle protein A2B-like, transcript variant X2
larval cuticle protein A2B-like, transcript variant X1
larval cuticle protein A2B-like isoform X2
larval cuticle protein A2B-like isoform X1
cysteine-rich hydrophobic domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 118 samples with support for all annotated introns
E3 ubiquitin-protein ligase arkadia-C-like, transcript variant X2
E3 ubiquitin-protein ligase arkadia-C-like, transcript variant X1
E3 ubiquitin-protein ligase arkadia-C-like
uncharacterized LOC125053924, transcript variant X2
uncharacterized LOC125053924, transcript variant X1
uncharacterized LOC125053922, transcript variant X2
uncharacterized LOC125053922, transcript variant X1
uncharacterized protein LOC125053922 isoform X1
uncharacterized protein LOC125053922 isoform X2
DNA-directed RNA polymerases I, II, and III subunit RPABC2
sarcalumenin-like, transcript variant X1
sarcalumenin-like, transcript variant X2
transfer RNA glycine (anticodon UCC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
aurora kinase B-like, transcript variant X1
aurora kinase B-like, transcript variant X2
aurora kinase B-like, transcript variant X3
repetitive organellar protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
repetitive organellar protein-like, transcript variant X1
ecdysone 20-monooxygenase, transcript variant X1
ecdysone 20-monooxygenase, transcript variant X2
ecdysone 20-monooxygenase, transcript variant X3
ecdysone 20-monooxygenase, transcript variant X4
uncharacterized LOC125053654, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC125053654, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized LOC125053654, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC125053654, transcript variant X5
uncharacterized LOC125053654, transcript variant X7
uncharacterized LOC125053654, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized protein LOC125053654 isoform X3
uncharacterized protein LOC125053654 isoform X4
uncharacterized protein LOC125053654 isoform X5
uncharacterized protein LOC125053654 isoform X6
uncharacterized protein LOC125053654 isoform X1
uncharacterized LOC125053654, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
uncharacterized protein LOC125053654 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
transfer RNA proline (anticodon AGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
dopamine receptor 2-like, transcript variant X1
dopamine receptor 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 52 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
regulator of gene activity-like, transcript variant X6
regulator of gene activity-like, transcript variant X4
regulator of gene activity-like, transcript variant X1
regulator of gene activity-like, transcript variant X5
regulator of gene activity-like, transcript variant X3
regulator of gene activity-like, transcript variant X2
CCR4-NOT transcription complex subunit 2-like isoform X4
regulator of gene activity-like isoform X3
regulator of gene activity-like isoform X5
regulator of gene activity-like isoform X1
regulator of gene activity-like isoform X2
glutamate [NMDA] receptor subunit 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
glutamate [NMDA] receptor subunit 1 isoform X1
glutamate [NMDA] receptor subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
glutamate [NMDA] receptor subunit 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
fibroblast growth factor 22, transcript variant X5
fibroblast growth factor 22, transcript variant X2
fibroblast growth factor 22, transcript variant X1
fibroblast growth factor 22, transcript variant X3
fibroblast growth factor 22, transcript variant X6
fibroblast growth factor 22, transcript variant X4
piggyBac transposable element-derived protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
uncharacterized LOC125054098, transcript variant X2
uncharacterized LOC125054098, transcript variant X1
uncharacterized LOC125054095, transcript variant X1
uncharacterized LOC125054095, transcript variant X2
uncharacterized protein LOC125054095 isoform X1
uncharacterized protein LOC125054095 isoform X2
calcium uptake protein 3, mitochondrial, transcript variant X3
calcium uptake protein 3, mitochondrial, transcript variant X1
calcium uptake protein 3, mitochondrial, transcript variant X2
calcium uptake protein 3, mitochondrial, transcript variant X4
calcium uptake protein 3, mitochondrial isoform X1
calcium uptake protein 3, mitochondrial isoform X3
calcium uptake protein 3, mitochondrial isoform X2
calcium uptake protein 3, mitochondrial isoform X4
zinc finger protein OZF-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
zinc finger protein OZF-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 59% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
knob-associated histidine-rich protein-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
phosphatidylinositol 4-kinase type 2-beta, transcript variant X1
phosphatidylinositol 4-kinase type 2-beta isoform X1
phosphatidylinositol 4-kinase type 2-beta, transcript variant X2
phosphatidylinositol 4-kinase type 2-beta isoform X2
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
FHF complex subunit HOOK interacting protein 2A-like, transcript variant X1
FHF complex subunit HOOK interacting protein 2A-like isoform X1
FHF complex subunit HOOK interacting protein 2A-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 150 samples with support for all annotated introns
FHF complex subunit HOOK interacting protein 2A-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
UDP-glucosyltransferase 2-like, transcript variant X3
UDP-glucosyltransferase 2-like, transcript variant X2
UDP-glucosyltransferase 2-like, transcript variant X1
UDP-glucosyltransferase 2-like isoform X1
UDP-glucosyltransferase 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 86 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
UDP-glucosyltransferase 2-like, transcript variant X4
UDP-glucosyltransferase 2-like isoform X4
UDP-glucosyltransferase 2-like isoform X3
UDP-glucosyltransferase 2-like, transcript variant X9
UDP-glucosyltransferase 2-like, transcript variant X6
UDP-glucosyltransferase 2-like isoform X6
UDP-glucosyltransferase 2-like, transcript variant X18
UDP-glucosyltransferase 2-like, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
UDP-glycosyltransferase UGT4-like isoform X15
UDP-glycosyltransferase UGT4-like isoform X16
UDP-glucosyltransferase 2-like, transcript variant X12
UDP-glucosyltransferase 2-like, transcript variant X14
UDP-glucosyltransferase 2-like, transcript variant X13
UDP-glucosyltransferase 2-like, transcript variant X11
UDP-glucosyltransferase 2-like, transcript variant X7
UDP-glucosyltransferase 2-like, transcript variant X17
UDP-glucosyltransferase 2-like, transcript variant X16
UDP-glucosyltransferase 2-like, transcript variant X8
UDP-glucosyltransferase 2-like isoform X9
UDP-glucosyltransferase 2-like isoform X11
UDP-glucosyltransferase 2-like isoform X12
UDP-glucosyltransferase 2-like isoform X7
UDP-glucosyltransferase 2-like isoform X14
UDP-glucosyltransferase 2-like isoform X10
UDP-glycosyltransferase UGT5-like isoform X1
UDP-glucosyltransferase 2-like, transcript variant X10
UDP-glucosyltransferase 2-like, transcript variant X5
UDP-glucosyltransferase 2-like, transcript variant X15
UDP-glucosyltransferase 2-like isoform X5
UDP-glucosyltransferase 2-like isoform X8
UDP-glucosyltransferase 2-like isoform X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
synaptic vesicle glycoprotein 2B-like, transcript variant X4
synaptic vesicle glycoprotein 2B-like, transcript variant X3
synaptic vesicle glycoprotein 2B-like, transcript variant X2
synaptic vesicle glycoprotein 2B-like isoform X4
synaptic vesicle glycoprotein 2B-like isoform X3
synaptic vesicle glycoprotein 2B-like isoform X2
synaptic vesicle glycoprotein 2B-like, transcript variant X1
synaptic vesicle glycoprotein 2B-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 137 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 115 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 28% coverage of the annotated genomic feature by RNAseq alignments
atrial natriuretic peptide receptor 1-like, transcript variant X2
atrial natriuretic peptide receptor 1-like, transcript variant X3
atrial natriuretic peptide receptor 1-like, transcript variant X1
atrial natriuretic peptide receptor 1-like isoform X2
atrial natriuretic peptide receptor 1-like isoform X1
atrial natriuretic peptide receptor 1-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 120 samples with support for all annotated introns
3-hydroxyacyl-CoA dehydrogenase type-2-like
mitochondrial import inner membrane translocase subunit Tim16
zinc finger CCHC domain-containing protein 10
DNA replication licensing factor Mcm2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
DNA replication licensing factor Mcm2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
DNA replication licensing factor Mcm2 isoform X1
DNA replication licensing factor Mcm2 isoform X2
eukaryotic translation initiation factor 2-alpha kinase, transcript variant X2
eukaryotic translation initiation factor 2-alpha kinase, transcript variant X1
eukaryotic translation initiation factor 2-alpha kinase isoform X1
eukaryotic translation initiation factor 2-alpha kinase isoform X2
eukaryotic translation initiation factor 2-alpha kinase, transcript variant X3
eukaryotic translation initiation factor 2-alpha kinase isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 117 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 82 samples with support for all annotated introns
biotin--protein ligase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
biotin--protein ligase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
microtubule-associated proteins 1A/1B light chain 3B-like, transcript variant X1
microtubule-associated proteins 1A/1B light chain 3B-like, transcript variant X2
uncharacterized protein LOC125053846 isoform X1
microtubule-associated proteins 1A/1B light chain 3B-like, transcript variant X3
microtubule-associated proteins 1A/1B light chain 3B-like isoform X2
mediator of RNA polymerase II transcription subunit 29
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 119 samples with support for all annotated introns
PF03932 family protein CutC, transcript variant X1
PF03932 family protein CutC, transcript variant X2
uncharacterized LOC125053948, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
uncharacterized LOC125053948, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125053913, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC125053913 isoform X3
uncharacterized LOC125053913, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
uncharacterized protein LOC125053913 isoform X1
uncharacterized LOC125053913, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
uncharacterized protein LOC125053913 isoform X2
uncharacterized LOC125054046, transcript variant X1
uncharacterized LOC125054046, transcript variant X2
uncharacterized protein LOC125054046 isoform X1
uncharacterized protein LOC125054046 isoform X2
atrial natriuretic peptide receptor 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125053830, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized protein LOC125053830 isoform X4
uncharacterized LOC125053830, transcript variant X4
uncharacterized protein LOC125053830 isoform X3
uncharacterized LOC125053830, transcript variant X2
uncharacterized LOC125053830, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
uncharacterized LOC125053830, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
uncharacterized protein LOC125053830 isoform X2
uncharacterized protein LOC125053830 isoform X1
uncharacterized LOC125053830, transcript variant X6
uncharacterized protein LOC125053830 isoform X5
succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial, transcript variant X2
succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial, transcript variant X1
succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial isoform X2
succinate--CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial isoform X1
mannose-1-phosphate guanyltransferase beta
probable DNA mismatch repair protein Msh6
palmitoyltransferase ZDHHC2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
palmitoyltransferase ZDHHC2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
palmitoyltransferase ZDHHC2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
palmitoyltransferase ZDHHC2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
palmitoyltransferase ZDHHC2-like isoform X4
palmitoyltransferase ZDHHC15B-like isoform X6
palmitoyltransferase ZDHHC15B-like isoform X2
palmitoyltransferase ZDHHC2-like isoform X1
palmitoyltransferase ZDHHC2-like, transcript variant X5
palmitoyltransferase ZDHHC2-like, transcript variant X3
palmitoyltransferase ZDHHC2-like, transcript variant X8
palmitoyltransferase ZDHHC2-like, transcript variant X7
palmitoyltransferase ZDHHC2-like isoform X7
palmitoyltransferase ZDHHC2-like isoform X8
palmitoyltransferase ZDHHC2-like isoform X5
palmitoyltransferase ZDHHC2-like isoform X3
protein capicua homolog, transcript variant X1
protein capicua homolog, transcript variant X2
protein capicua homolog, transcript variant X3
distal membrane-arm assembly complex protein 2
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97% coverage of the annotated genomic feature by RNAseq alignments
adhesive plaque matrix protein-like, transcript variant X3
adhesive plaque matrix protein-like, transcript variant X4
adhesive plaque matrix protein-like, transcript variant X1
adhesive plaque matrix protein-like, transcript variant X2
adhesive plaque matrix protein-like isoform X3
probable serine/threonine-protein kinase kinX isoform X1
adhesive plaque matrix protein-like isoform X2
mothers against decapentaplegic homolog 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
mothers against decapentaplegic homolog 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
mothers against decapentaplegic homolog 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 61 samples with support for all annotated introns
mothers against decapentaplegic homolog 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 83 samples with support for all annotated introns
mothers against decapentaplegic homolog 4 isoform X4
mothers against decapentaplegic homolog 4 isoform X3
mothers against decapentaplegic homolog 4 isoform X2
mothers against decapentaplegic homolog 4 isoform X1
trafficking protein particle complex subunit 10
katanin p60 ATPase-containing subunit A-like 1
trithorax group protein osa, transcript variant X1
trithorax group protein osa, transcript variant X13
trithorax group protein osa, transcript variant X6
trithorax group protein osa, transcript variant X10
trithorax group protein osa, transcript variant X15
trithorax group protein osa, transcript variant X3
trithorax group protein osa, transcript variant X11
trithorax group protein osa, transcript variant X4
trithorax group protein osa, transcript variant X5
trithorax group protein osa, transcript variant X14
trithorax group protein osa, transcript variant X2
trithorax group protein osa, transcript variant X7
trithorax group protein osa, transcript variant X9
trithorax group protein osa, transcript variant X12
trithorax group protein osa, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
tight junction protein ZO-1, transcript variant X3
tight junction protein ZO-1, transcript variant X5
tight junction protein ZO-1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 76 samples with support for all annotated introns
tight junction protein ZO-1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
tight junction protein ZO-1, transcript variant X1
tight junction protein ZO-1, transcript variant X2
tight junction protein ZO-1, transcript variant X4
tight junction protein ZO-1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
tight junction protein ZO-1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 86 samples with support for all annotated introns
tight junction protein ZO-1, transcript variant X6
tight junction protein ZO-1, transcript variant X9
tight junction protein ZO-1, transcript variant X10
PIN2/TERF1-interacting telomerase inhibitor 1
tight junction protein ZO-1, transcript variant X8
leucine-rich repeat-containing protein 71-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
FHIP family protein GF15501, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 160 samples with support for all annotated introns
FHIP family protein GF15501, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 154 samples with support for all annotated introns
FHIP family protein AGAP011705 isoform X2
SWI/SNF complex subunit SMARCC2, transcript variant X2
SWI/SNF complex subunit SMARCC2, transcript variant X1
SWI/SNF complex subunit SMARCC2 isoform X2
SWI/SNF complex subunit SMARCC2 isoform X1
mitochondrial glutamate carrier 1-like, transcript variant X1
mitochondrial glutamate carrier 1-like, transcript variant X2
tRNA pseudouridine synthase A, transcript variant X1
tRNA pseudouridine synthase A, transcript variant X2
tRNA pseudouridine synthase A isoform X1
tRNA pseudouridine synthase A isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 150 samples with support for all annotated introns
protein jim lovell-like, transcript variant X1
protein jim lovell-like, transcript variant X2
protein jim lovell-like, transcript variant X3
protein jim lovell-like, transcript variant X4
zinc finger and BTB domain-containing protein 17-like isoform X2
B-cell receptor CD22-like, transcript variant X2
B-cell receptor CD22-like, transcript variant X1
uncharacterized LOC125054239, transcript variant X2
uncharacterized LOC125054239, transcript variant X1
probable 39S ribosomal protein L45, mitochondrial
regulator of G-protein signaling loco, transcript variant X3
regulator of G-protein signaling loco, transcript variant X1
regulator of G-protein signaling loco, transcript variant X2
regulator of G-protein signaling loco, transcript variant X4
regulator of G-protein signaling loco, transcript variant X5
regulator of G-protein signaling loco isoform X3
regulator of G-protein signaling loco isoform X1
regulator of G-protein signaling loco isoform X2
regulator of G-protein signaling loco isoform X4
regulator of G-protein signaling loco isoform X5
regulator of G-protein signaling loco-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
myosin heavy chain, embryonic smooth muscle isoform
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
trafficking protein particle complex subunit 2
DNA-directed RNA polymerase III subunit RPC4, transcript variant X3
DNA-directed RNA polymerase III subunit RPC4, transcript variant X1
DNA-directed RNA polymerase III subunit RPC4, transcript variant X2
DNA-directed RNA polymerase III subunit RPC4
probable 28S ribosomal protein S26, mitochondrial
calcineurin-binding protein cabin-1-like
proclotting enzyme-like, transcript variant X1
proclotting enzyme-like, transcript variant X2
glutamate-gated chloride channel, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 30 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
glutamate-gated chloride channel, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
glutamate-gated chloride channel isoform X3
glutamate-gated chloride channel isoform X6
glutamate-gated chloride channel isoform X2
glutamate-gated chloride channel isoform X5
glutamate-gated chloride channel isoform X1
glutamate-gated chloride channel isoform X4
ATP synthase subunit b, mitochondrial, transcript variant X1
ATP synthase subunit b, mitochondrial, transcript variant X2
ATP synthase subunit b, mitochondrial isoform X2
ATP synthase subunit b, mitochondrial isoform X1
small VCP/p97-interacting protein, transcript variant X2
uncharacterized protein LOC125053792 isoform X2
small VCP/p97-interacting protein, transcript variant X1
small VCP/p97-interacting protein isoform X1
solute carrier organic anion transporter family member 1B2-like, transcript variant X2
solute carrier organic anion transporter family member 1B2-like, transcript variant X1
solute carrier organic anion transporter family member 1B2-like
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X3
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X1
UTP--glucose-1-phosphate uridylyltransferase isoform X1
UTP--glucose-1-phosphate uridylyltransferase isoform X3
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X5
UTP--glucose-1-phosphate uridylyltransferase isoform X5
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X4
UTP--glucose-1-phosphate uridylyltransferase isoform X4
UTP--glucose-1-phosphate uridylyltransferase, transcript variant X2
UTP--glucose-1-phosphate uridylyltransferase isoform X2
solute carrier organic anion transporter family member 74D-like
venom protease-like, transcript variant X2
venom protease-like, transcript variant X1
venom serine protease Bi-VSP-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 107 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 8, transcript variant X1
ubiquitin carboxyl-terminal hydrolase 8, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 8 isoform X1
ubiquitin carboxyl-terminal hydrolase 8 isoform X2
synapse-associated protein of 47 kDa, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 111 samples with support for all annotated introns
synapse-associated protein of 47 kDa, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 80 samples with support for all annotated introns
synapse-associated protein of 47 kDa, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 147 samples with support for all annotated introns
synapse-associated protein of 47 kDa, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
synapse-associated protein of 47 kDa, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 163 samples with support for all annotated introns
synapse-associated protein of 47 kDa, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 137 samples with support for all annotated introns
synapse-associated protein of 47 kDa, transcript variant X9
synapse-associated protein of 47 kDa, transcript variant X10
synapse-associated protein of 47 kDa, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 148 samples with support for all annotated introns
synapse-associated protein of 47 kDa, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 164 samples with support for all annotated introns
synapse-associated protein of 47 kDa isoform X1
synapse-associated protein of 47 kDa isoform X7
synapse-associated protein of 47 kDa isoform X2
synapse-associated protein of 47 kDa isoform X5
synapse-associated protein of 47 kDa isoform X3
synapse-associated protein of 47 kDa isoform X4
synapse-associated protein of 47 kDa isoform X6
synapse-associated protein of 47 kDa isoform X8
synapse-associated protein of 47 kDa isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
inverted formin-2, transcript variant X1
inverted formin-2, transcript variant X3
inverted formin-2, transcript variant X2
cyclin-dependent kinases regulatory subunit-like
dystrophin, isoforms A/C/F/G/H-like, transcript variant X2
dystrophin, isoforms A/C/F/G/H-like, transcript variant X6
dystrophin, isoforms A/C/F/G/H-like, transcript variant X1
dystrophin, isoforms A/C/F/G/H-like, transcript variant X3
dystrophin, isoforms A/C/F/G/H-like, transcript variant X8
dystrophin, isoforms A/C/F/G/H-like, transcript variant X7
dystrophin, isoforms A/C/F/G/H-like, transcript variant X4
dystrophin, isoforms A/C/F/G/H-like isoform X5
dystrophin, isoforms A/C/F/G/H-like isoform X2
dystrophin, isoforms A/C/F/G/H-like isoform X1
dystrophin, isoforms A/C/F/G/H-like isoform X3
dystrophin, isoforms A/C/F/G/H-like, transcript variant X5
dystrophin, isoforms A/C/F/G/H-like isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
uncharacterized LOC125053673, transcript variant X1
uncharacterized LOC125053673, transcript variant X3
uncharacterized LOC125053673, transcript variant X4
uncharacterized LOC125053673, transcript variant X2
uncharacterized protein LOC125053673 isoform X1
uncharacterized protein LOC125053673 isoform X3
uncharacterized protein LOC125053673 isoform X4
uncharacterized protein LOC125053673 isoform X2
uncharacterized LOC125053824, transcript variant X1
uncharacterized LOC125053824, transcript variant X2
uncharacterized protein LOC125053824 isoform X1
uncharacterized protein LOC125053824 isoform X2
uncharacterized LOC125053821, transcript variant X2
uncharacterized LOC125053821, transcript variant X4
uncharacterized LOC125053821, transcript variant X1
uncharacterized LOC125053821, transcript variant X3
uncharacterized LOC125053821, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
uncharacterized protein LOC125053821 isoform X1
uncharacterized protein LOC125053821 isoform X2
uncharacterized protein LOC125053821 isoform X3
uncharacterized protein LOC125053821 isoform X4
uncharacterized LOC125053626, transcript variant X2
uncharacterized LOC125053626, transcript variant X1
uncharacterized protein LOC125053626 isoform X1
uncharacterized protein LOC125053626 isoform X2
uncharacterized LOC125053626, transcript variant X3
uncharacterized LOC125053626, transcript variant X4
uncharacterized protein LOC125053626 isoform X3
uncharacterized LOC125053633, transcript variant X1
uncharacterized LOC125053633, transcript variant X3
uncharacterized LOC125053633, transcript variant X2
uncharacterized protein LOC125053633 isoform X1
uncharacterized protein LOC125053633 isoform X3
uncharacterized protein LOC125053633 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 160 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 96 samples with support for all annotated introns
mediator of RNA polymerase II transcription subunit 1
orcokinin peptides-like, transcript variant X3
orcokinin peptides-like, transcript variant X2
orcokinin peptides-like, transcript variant X1
uncharacterized protein LOC125053647 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
putative phospholipase B-like lamina ancestor
aryl hydrocarbon receptor nuclear translocator-like protein 1
KRR1 small subunit processome component homolog
NFX1-type zinc finger-containing protein 1-like, transcript variant X2
NFX1-type zinc finger-containing protein 1-like, transcript variant X1
NFX1-type zinc finger-containing protein 1-like isoform X2
NFX1-type zinc finger-containing protein 1-like isoform X1
DNA (cytosine-5)-methyltransferase PliMCI-like, transcript variant X1
DNA (cytosine-5)-methyltransferase PliMCI-like, transcript variant X3
DNA (cytosine-5)-methyltransferase PliMCI-like, transcript variant X2
DNA (cytosine-5)-methyltransferase PliMCI-like isoform X1
DNA (cytosine-5)-methyltransferase PliMCI-like isoform X2
TP53-regulated inhibitor of apoptosis 1-like
uncharacterized LOC125053640, transcript variant X1
uncharacterized LOC125053640, transcript variant X2
uncharacterized LOC125053640, transcript variant X4
uncharacterized LOC125053640, transcript variant X3
uncharacterized protein LOC125053640 isoform X1
uncharacterized protein LOC125053640 isoform X2
uncharacterized protein LOC125053640 isoform X4
uncharacterized protein LOC125053640 isoform X3
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 95 samples with support for all annotated introns
transmembrane protein 19, transcript variant X2
transmembrane protein 19, transcript variant X1
signal recognition particle receptor subunit beta
pyridoxine/pyridoxamine 5'-phosphate oxidase-like, transcript variant X2
pyridoxine/pyridoxamine 5'-phosphate oxidase-like, transcript variant X3
pyridoxine/pyridoxamine 5'-phosphate oxidase-like, transcript variant X1
pyridoxine/pyridoxamine 5'-phosphate oxidase-like, transcript variant X4
pyridoxine/pyridoxamine 5'-phosphate oxidase-like isoform X1
pyridoxine/pyridoxamine 5'-phosphate oxidase-like isoform X2
histidine protein methyltransferase 1 homolog, transcript variant X4
histidine protein methyltransferase 1 homolog, transcript variant X2
histidine protein methyltransferase 1 homolog, transcript variant X5
histidine protein methyltransferase 1 homolog, transcript variant X1
histidine protein methyltransferase 1 homolog, transcript variant X3
histidine protein methyltransferase 1 homolog isoform X1
histidine protein methyltransferase 1 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 168 samples with support for all annotated introns
histidine protein methyltransferase 1 homolog isoform X2
proteasome activator complex subunit 3, transcript variant X1
proteasome activator complex subunit 3, transcript variant X2
proteasome activator complex subunit 3 isoform X1
proteasome activator complex subunit 3 isoform X2
proteasome activator complex subunit 3, transcript variant X4
proteasome activator complex subunit 3, transcript variant X3
proteasome activator complex subunit 3 isoform X3
proteasome activator complex subunit 3 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
malate dehydrogenase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 65% coverage of the annotated genomic feature by RNAseq alignments
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X3
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X6
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X3
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X6
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X4
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X5
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X1
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog, transcript variant X2
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X1
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X4
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X2
interferon-inducible double-stranded RNA-dependent protein kinase activator A homolog isoform X5
putative uncharacterized protein DDB_G0282133
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
dynein regulatory complex subunit 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
inositol polyphosphate 5-phosphatase K-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 64 samples with support for all annotated introns
inositol polyphosphate 5-phosphatase K-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 81 samples with support for all annotated introns
inositol polyphosphate 5-phosphatase K-like isoform X1
inositol polyphosphate 5-phosphatase K-like isoform X2
F-box/LRR-repeat protein 4, transcript variant X1
F-box/LRR-repeat protein 4, transcript variant X2
uncharacterized LOC125053575, transcript variant X1
uncharacterized LOC125053575, transcript variant X2
uncharacterized protein LOC125053575 isoform X1
uncharacterized protein LOC125053575 isoform X2
serine-enriched protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
serine-enriched protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
serine-enriched protein, transcript variant X3
putative polypeptide N-acetylgalactosaminyltransferase 9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X2
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X3
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X5
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X4
putative polypeptide N-acetylgalactosaminyltransferase 9, transcript variant X1
putative polypeptide N-acetylgalactosaminyltransferase 9 isoform X3
putative polypeptide N-acetylgalactosaminyltransferase 9 isoform X2
putative polypeptide N-acetylgalactosaminyltransferase 9 isoform X1
uncharacterized LOC125053999, transcript variant X1
uncharacterized LOC125053999, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 60 samples with support for all annotated introns
uncharacterized protein LOC125053999 isoform X1
uncharacterized protein LOC125053999 isoform X2
leucine-rich repeat and IQ domain-containing protein 4-like, transcript variant X1
leucine-rich repeat and IQ domain-containing protein 4-like, transcript variant X2
leucine-rich repeat and IQ domain-containing protein 4-like
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3-like
PAN2-PAN3 deadenylation complex catalytic subunit PAN2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
putative cyclic nucleotide-gated ion channel 9
TWiK family of potassium channels protein 7-like
POU domain, class 6, transcription factor 2, transcript variant X2
POU domain, class 6, transcription factor 2, transcript variant X4
POU domain, class 6, transcription factor 2, transcript variant X1
POU domain, class 6, transcription factor 2, transcript variant X6
POU domain, class 6, transcription factor 2, transcript variant X7
POU domain, class 6, transcription factor 2, transcript variant X3
POU domain, class 6, transcription factor 2 isoform X1
POU domain, class 6, transcription factor 2 isoform X4
POU domain, class 6, transcription factor 1 isoform X5
POU domain, class 6, transcription factor 2 isoform X2
POU domain, class 6, transcription factor 2, transcript variant X5
POU domain, class 6, transcription factor 2 isoform X3
tyrosine-protein phosphatase non-receptor type 4, transcript variant X2
tyrosine-protein phosphatase non-receptor type 4, transcript variant X1
tyrosine-protein phosphatase non-receptor type 4 isoform X1
tyrosine-protein phosphatase non-receptor type 4 isoform X2
fibroblast growth factor receptor 3-like
hepatitis A virus cellular receptor 1-like
BMP and activin membrane-bound inhibitor homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 162 samples with support for all annotated introns
4-hydroxyphenylpyruvate dioxygenase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125053902, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC125053902, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC125053902, transcript variant X1
uncharacterized protein LOC125053902 isoform X2
uncharacterized protein LOC125053902 isoform X3
uncharacterized protein LOC125053902 isoform X1
rho guanine nucleotide exchange factor 10-like protein, transcript variant X3
rho guanine nucleotide exchange factor 10-like protein, transcript variant X1
rho guanine nucleotide exchange factor 10-like protein, transcript variant X2
rho guanine nucleotide exchange factor 10-like protein, transcript variant X4
rho guanine nucleotide exchange factor 10-like protein isoform X3
rho guanine nucleotide exchange factor 10-like protein isoform X1
rho guanine nucleotide exchange factor 10-like protein isoform X2
rho guanine nucleotide exchange factor 10-like protein isoform X4
uncharacterized LOC125053721, transcript variant X1
uncharacterized LOC125053721, transcript variant X5
uncharacterized LOC125053721, transcript variant X4
uncharacterized LOC125053721, transcript variant X2
uncharacterized LOC125053721, transcript variant X3
uncharacterized protein LOC125053721 isoform X3
uncharacterized protein LOC125053721 isoform X4
uncharacterized protein LOC125053721 isoform X1
uncharacterized protein LOC125053721 isoform X2
serine--pyruvate aminotransferase, mitochondrial
dorsal-ventral patterning protein Sog, transcript variant X1
dorsal-ventral patterning protein Sog, transcript variant X2
dorsal-ventral patterning protein Sog isoform X1
dorsal-ventral patterning protein Sog isoform X2
tRNA (cytosine(72)-C(5))-methyltransferase NSUN6
putative tRNA (cytidine(32)/guanosine(34)-2'-O)-methyltransferase
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6
calcium-binding protein E63-1, transcript variant X2
calcium-binding protein E63-1, transcript variant X1
calcium-binding protein E63-1, transcript variant X6
calcium-binding protein E63-1, transcript variant X5
calcium-binding protein E63-1, transcript variant X4
calcium-binding protein E63-1, transcript variant X3
calcium-binding protein E63-1, transcript variant X7
calcium-binding protein E63-1 isoform X2
calcium-binding protein E63-1 isoform X1
calcium-binding protein E63-1 isoform X4
calcium-binding protein E63-1 isoform X3
calcium-binding protein E63-1 isoform X6
calcium-binding protein E63-1 isoform X5
calcium-binding protein E63-1 isoform X7
trypsin alpha-3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
trypsin alpha-3-like, transcript variant X2
transmembrane protease serine 5-like isoform X2
cytoplasmic phosphatidylinositol transfer protein 1
trafficking protein particle complex subunit 13
clustered mitochondria protein homolog, transcript variant X2
clustered mitochondria protein homolog, transcript variant X1
clustered mitochondria protein homolog isoform X1
clustered mitochondria protein homolog isoform X2
ubiquitin carboxyl-terminal hydrolase calypso
DNA-directed RNA polymerase II subunit Rpb4
protein FAM117B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
protein FAM117B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 95 samples with support for all annotated introns
protein FAM117B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 101 samples with support for all annotated introns
protein FAM117B-like, transcript variant X4
protein FAM117B-like, transcript variant X5
ubiquitin conjugation factor E4 A, transcript variant X2
ubiquitin conjugation factor E4 A, transcript variant X1
ubiquitin conjugation factor E4 A isoform X2
ubiquitin conjugation factor E4 A isoform X1
protein suppressor of sable, transcript variant X2
protein suppressor of sable, transcript variant X1
protein suppressor of sable, transcript variant X3
intraflagellar transport protein 22 homolog
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
biogenesis of lysosome-related organelles complex 1 subunit 1
lysophospholipid acyltransferase 7-like, transcript variant X1
lysophospholipid acyltransferase 7-like, transcript variant X2
lysophospholipid acyltransferase 7-like, transcript variant X4
lysophospholipid acyltransferase 7-like isoform X1
lysophospholipid acyltransferase 7-like isoform X4
lysophospholipid acyltransferase 7-like, transcript variant X3
lysophospholipid acyltransferase 7-like isoform X3
lysophospholipid acyltransferase 7-like isoform X2
G protein-coupled receptor kinase 1, transcript variant X1
G protein-coupled receptor kinase 1, transcript variant X2
G protein-coupled receptor kinase 1 isoform X2
G protein-coupled receptor kinase 1 isoform X1
ATP-binding cassette sub-family B member 6
peptidyl-prolyl cis-trans isomerase G-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase G-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase G-like isoform X2
peptidyl-prolyl cis-trans isomerase G-like isoform X1
HEAT repeat-containing protein 6, transcript variant X1
HEAT repeat-containing protein 6, transcript variant X2
HEAT repeat-containing protein 6 isoform X1
HEAT repeat-containing protein 6 isoform X2
HEAT repeat-containing protein 6, transcript variant X3
HEAT repeat-containing protein 6 isoform X3
uncharacterized LOC125054161, transcript variant X1
uncharacterized protein LOC125054161 isoform X1
uncharacterized LOC125054161, transcript variant X2
uncharacterized protein LOC125054161 isoform X2
integrin alpha-PS1, transcript variant X1
integrin alpha-PS1, transcript variant X2
dual oxidase maturation factor 2, transcript variant X2
dual oxidase maturation factor 2, transcript variant X3
dual oxidase maturation factor 2, transcript variant X1
EF-hand domain-containing family member C2, transcript variant X1
EF-hand domain-containing family member C2, transcript variant X2
EF-hand domain-containing family member C2 isoform X1
EF-hand domain-containing family member C2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ragulator complex protein LAMTOR4 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 141 samples with support for all annotated introns
ragulator complex protein LAMTOR4 homolog, transcript variant X1
ragulator complex protein LAMTOR4 homolog isoform X1
ragulator complex protein LAMTOR4 homolog isoform X2
translocon-associated protein subunit gamma
uncharacterized LOC125054036, transcript variant X3
uncharacterized LOC125054036, transcript variant X1
uncharacterized LOC125054036, transcript variant X2
uncharacterized protein LOC125054036 isoform X2
uncharacterized protein LOC125054036 isoform X1
uncharacterized LOC125054036, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
uncharacterized LOC125054036, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
uncharacterized protein LOC125054036 isoform X3
lysosomal-associated transmembrane protein 4A
condensin complex subunit 1, transcript variant X1
condensin complex subunit 1, transcript variant X2